| Patty Kang, PHARMD | |
|
2001 Santa Monica Blvd, Santa Monica, CA 90404-2102 | |
| (310) 829-3401 | |
| Not Available |
| Full Name | Patty Kang |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2001 Santa Monica Blvd, Santa Monica, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134691280 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 52351 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Patty Kang, PHARMD 3471 Via Lido Ste 200, Newport Beach, CA 92663-3926 Ph: (949) 640-1231 | Patty Kang, PHARMD 2001 Santa Monica Blvd, Santa Monica, CA 90404-2102 Ph: (310) 829-3401 |
News Archive
Regulus Therapeutics Inc. announced today that the Company has received a $10 million equity investment from sanofi-aventis in connection with the landmark alliance the two companies entered into on June 21, 2010. The equity investment by sanofi-aventis further strengthens the balance sheet of Regulus, and with this investment sanofi-aventis becomes the third investor in Regulus, along with its founding companies Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc..
Tengion, Inc., a leader in regenerative medicine, announced today that the scheduled one-month, post-operative clinical assessment of the first implanted bladder cancer patient in its ongoing clinical trial has been completed as expected and has permitted the second patient to be enrolled without delay.
A recent study published on the preprint server medRxiv* in October 2020 reports the potential contribution of vitamin D deficiency to an increased risk of COVID-19 in a subset of health care workers in the UK.
Up to 20 percent of Parkinson's disease (PD) patients and their families may confront a common but largely unrecognized challenge: the occurrence of impulse control disorders (ICDs) such as compulsive gambling, sexual behavior, eating, or spending.
Nobilon, the human vaccine business unit of Schering-Plough Corporation (NYSE: SGP), today announced that it has initiated a clinical Proof of Concept trial with SCH 900795, a new intranasal Live Attenuated Influenza Vaccine (LAIV) for annual seasonal use.
› Verified 3 days ago
Christine Pham, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1250 16th St, Santa Monica, CA 90404 Phone: 414-259-8500 | |
Dr. Abe Javaheri, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2412 Pico Blvd, Santa Monica, CA 90405 Phone: 310-450-7624 | |
Tanaz Refalian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3202 Wilshire Blvd, Santa Monica, CA 90403 Phone: 310-829-5523 | |
Rachelle Daun Ancona, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2020 Santa Monica Blvd, Santa Monica, CA 90404 Phone: 323-223-7847 Fax: 310-582-6238 | |
Annie Lim, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1908 Santa Monica Blvd Ste 4, Santa Monica, CA 90404 Phone: 310-315-9999 | |
Niousha Nader, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1250 16th St, Santa Monica, CA 90404 Phone: 424-259-8506 | |
Behnam Amir-behboudi, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2505 Santa Monica Blvd, Santa Monica, CA 90404 Phone: 310-828-6456 |